MAM
Freedom Healthy Cooking Oils unveils branding at Moosapet Metro Station
Mumbai: Freedom Healthy Cooking Oils has boosted its visibility by branding Moosapet Metro Station in Hyderabad, now renamed Freedom Oil Moosapet Station. This move is part of the brand’s strategy to reach a wider audience and promote heart-healthy cooking oils. The station’s visuals highlight Freedom’s message of making healthy cooking accessible, showcasing oils like rice bran, sunflower, mustard, and groundnut, all low in saturated fats and rich in nutrients.
Located in a busy area with thousands of daily commuters, the station provides Freedom with a platform to educate consumers on the health benefits of its oils, encouraging informed choices. This initiative supports the brand’s mission to promote healthier living and enhance its presence in one of Hyderabad’s busiest metro stations.
Freedom Healthy Cooking Oils’ SVP of sales & marketing, P Chandrashekara Reddy said, “We at Freedom Healthy Cooking Oils are excited to be a part of the daily journey of thousands of commuters through our partnership with Moosapet Metro Station. This initiative reflects our mission to inspire healthier cooking habits by providing oils that are not only rich in nutrients but also support heart health. We hope to make a lasting impact on the community, encouraging people to make better choices for themselves and their families.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
